Study on the dose ratio of Chlorogenic acid-Geniposide to treat rats with experimental fatty liver based on uniform design
- 医学院－已发表论文 
目的:运用均匀设计法优化绿原酸-栀子苷组合治疗实验性脂肪肝大鼠的最佳剂量配比,探讨中药有效成分配伍配比规律。方法:运用数学模型均匀设计法对绿原酸; -栀子苷组合中的2种中药有效成分进行分组设计,分为6种组合对高脂饮食诱导的实验性脂肪肝大鼠模型进行治疗,观察各组大鼠肝脏的病理变化,并以肝组织甘; 油三酯(TG)、血清低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、总胆固醇(CHO)、谷丙转氨酶(ALT)、谷草转氨酶(A; ST)测定作为筛选指标,优选二者的最优剂量配比,并根据所得重新分组验证。结果:与正常组比较,模型组脂肪肝大鼠肝组织TG、血清LDL-C、CHO含; 量明显升高(P<0.01),血清HDL-C含量明显降低(P<0.01),血清ALT、AST活性明显升高(P<0.01),肝组织存在明显脂肪变性。; 经多元逐步回归分析,绿原酸-栀子苷组合治疗脂肪肝的最佳剂量配比是绿原酸90mg+栀子苷90mg。结论:应用均匀设计与药效学分析的方法可有效优化中; 药有效成分组合的最佳剂量配比。Objective: To explore the active ingredients and dose ratio of medicine,; combined with the optimal dose ratio of Chlorogenic acid-Geniposide to; treat rats with experimental fatty liver. Methods: The active; ingredients and optimized prescription were screened out, adopting; uniform design to divide Chlorogenic acid-Geniposide into six; combinations, by using experiment on high fat diet-induced fatty liver; rat models, and the pathological results were observed. The serum LDL-C,; HDL-C, CHO, ALT, AST and liver TG were taken as the screening-indexes.; Results: Compared with the normal groups, the serum LDL-C, CHO, ALT, AST; and liver TG in model groups were significantly higher (P<0.01), the; serum HDL-C in model group was significantly decreased (P<0.01), and the; pathology of liver tissue got obvious steatosis. According to stepwise; regression analysis of uniform design, the best ratio of Chlorogenic; acid-Geniposide to anti-NAFLD were Chlorogenic acid 90mg with Geniposide; 90mg. Conclusion: Uniform design is the appropriate way to confirm the; optimized prescription for active ingredient of Chinese medicine.